These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34678758)

  • 1. Effects of estradiol on fat in men undergoing androgen deprivation therapy: a randomized trial.
    Russell N; Hoermann R; Cheung AS; Zajac JD; Handelsman DJ; Grossmann M
    Eur J Endocrinol; 2021 Nov; 186(1):9-23. PubMed ID: 34678758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of estradiol on bone in men undergoing androgen deprivation therapy: a randomized placebo-controlled trial.
    Russell N; Ghasem-Zadeh A; Hoermann R; Cheung AS; Zajac JD; Shore-Lorenti C; Ebeling PR; Handelsman DJ; Grossmann M
    Eur J Endocrinol; 2022 Aug; 187(2):241-256. PubMed ID: 35666800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of testosterone treatment on body fat and lean mass in obese men on a hypocaloric diet: a randomised controlled trial.
    Ng Tang Fui M; Prendergast LA; Dupuis P; Raval M; Strauss BJ; Zajac JD; Grossmann M
    BMC Med; 2016 Oct; 14(1):153. PubMed ID: 27716209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
    Taaffe DR; Buffart LM; Newton RU; Spry N; Denham J; Joseph D; Lamb D; Chambers SK; Galvão DA
    BJU Int; 2018 Feb; 121(2):194-202. PubMed ID: 28872752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between insulin resistance and frailty with body composition and testosterone in men undergoing androgen deprivation therapy for prostate cancer.
    Cheung AS; Hoermann R; Dupuis P; Joon DL; Zajac JD; Grossmann M
    Eur J Endocrinol; 2016 Sep; 175(3):229-37. PubMed ID: 27340081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term effects of transdermal estradiol in men undergoing androgen deprivation therapy for prostate cancer: a randomized placebo-controlled trial.
    Russell N; Hoermann R; Cheung AS; Ching M; Zajac JD; Handelsman DJ; Grossmann M
    Eur J Endocrinol; 2018 May; 178(5):565-576. PubMed ID: 29549104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oestradiol treatment on hot flushes in men undergoing androgen deprivation therapy for prostate cancer: a randomised placebo-controlled trial.
    Russell N; Hoermann R; Cheung AS; Zajac JD; Grossmann M
    Eur J Endocrinol; 2022 Nov; 187(5):617-627. PubMed ID: 36806623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer.
    Galvão DA; Spry NA; Taaffe DR; Newton RU; Stanley J; Shannon T; Rowling C; Prince R
    BJU Int; 2008 Jul; 102(1):44-7. PubMed ID: 18336606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of estradiol on cognition in men undergoing androgen deprivation therapy: A randomized placebo-controlled trial.
    Russell N; Allebone J; Dandash O; Hoermann R; Cheung AS; Zajac JD; Handelsman DJ; Kanaan RA; Grossmann M
    Clin Endocrinol (Oxf); 2022 Nov; 97(5):622-633. PubMed ID: 35150156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone with dutasteride, but not anastrazole, improves insulin sensitivity in young obese men: a randomized controlled trial.
    Juang PS; Peng S; Allehmazedeh K; Shah A; Coviello AD; Herbst KL
    J Sex Med; 2014 Feb; 11(2):563-73. PubMed ID: 24344872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of 6 months of androgen deprivation therapy on muscle and fat mass in older men with localized prostate cancer.
    Boxer RS; Kenny AM; Dowsett R; Taxel P
    Aging Male; 2005; 8(3-4):207-12. PubMed ID: 16390748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of testosterone on body composition in obese men are not sustained after cessation of testosterone treatment.
    Ng Tang Fui M; Hoermann R; Zajac JD; Grossmann M
    Clin Endocrinol (Oxf); 2017 Oct; 87(4):336-343. PubMed ID: 28561278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.
    Bhasin S; Parker RA; Sattler F; Haubrich R; Alston B; Umbleja T; Shikuma CM;
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1049-57. PubMed ID: 17164307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy.
    Berruti A; Dogliotti L; Terrone C; Cerutti S; Isaia G; Tarabuzzi R; Reimondo G; Mari M; Ardissone P; De Luca S; Fasolis G; Fontana D; Rossetti SR; Angeli A;
    J Urol; 2002 Jun; 167(6):2361-7; discussion 2367. PubMed ID: 11992038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial.
    Sinclair M; Grossmann M; Hoermann R; Angus PW; Gow PJ
    J Hepatol; 2016 Nov; 65(5):906-913. PubMed ID: 27312945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men.
    Lovejoy JC; Bray GA; Greeson CS; Klemperer M; Morris J; Partington C; Tulley R
    Int J Obes Relat Metab Disord; 1995 Sep; 19(9):614-24. PubMed ID: 8574271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persisting adverse body composition changes 2 years after cessation of androgen deprivation therapy for localised prostate cancer.
    Cheung AS; Tinson AJ; Milevski SV; Hoermann R; Zajac JD; Grossmann M
    Eur J Endocrinol; 2018 Jul; 179(1):21-29. PubMed ID: 29712718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate versus delayed exercise in men initiating androgen deprivation: effects on bone density and soft tissue composition.
    Taaffe DR; Galvão DA; Spry N; Joseph D; Chambers SK; Gardiner RA; Hayne D; Cormie P; Shum DHK; Newton RU
    BJU Int; 2019 Feb; 123(2):261-269. PubMed ID: 30239116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic consequences of gonadotropin-releasing hormone agonists vs orchiectomy: a randomized clinical study.
    Østergren PB; Kistorp C; Fode M; Bennedbaek FN; Faber J; Sønksen J
    BJU Int; 2019 Apr; 123(4):602-611. PubMed ID: 30388320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.
    Allan CA; Strauss BJ; Burger HG; Forbes EA; McLachlan RI
    J Clin Endocrinol Metab; 2008 Jan; 93(1):139-46. PubMed ID: 17940111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.